Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection
- PMID: 14961982
- DOI: 10.1111/j.1600-6143.2004.00348.x
Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection
Abstract
Complement is a multifunctional system of receptors and regulators as well as effector molecules. Both the pathogenic and diagnostic power of complement is based on the capacity of the complement system to amplify innate and adaptive immunity. This amplification is accomplished through two strategies: (1) enzymatic reactions in the complement cascade, and (2) stimulation of leukocytes, platelets and parenchymal cells through specific receptors or receptor-independent pore formation. The mechanisms by which complement mediates and modifies nonspecific inflammation, antibody-mediated injury and T-cell responses are of particular significance to the pathogenesis of transplant rejection. Understanding the mechanisms by which complement integrates the interactions of leukocytes, platelets and parenchymal cells offers opportunities to further refine the diagnosis of rejection.
Similar articles
-
The impact of C4d testing on tissue adequacy in lung transplant surveillance.Ann Diagn Pathol. 2020 Oct;48:151564. doi: 10.1016/j.anndiagpath.2020.151564. Epub 2020 Jul 2. Ann Diagn Pathol. 2020. PMID: 32659621
-
Morphologic and immunohistochemical findings in antibody-mediated rejection of the cardiac allograft.Hum Immunol. 2012 Dec;73(12):1213-7. doi: 10.1016/j.humimm.2012.07.011. Epub 2012 Jul 16. Hum Immunol. 2012. PMID: 22813651 Review.
-
Diagnosis and treatment of antibody-mediated kidney allograft rejection.Transpl Int. 2003 Nov;16(11):773-87. doi: 10.1007/s00147-003-0658-3. Epub 2003 Oct 8. Transpl Int. 2003. PMID: 14534774 Review.
-
Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4.Transplantation. 2012 May 15;93(9):867-73. doi: 10.1097/TP.0b013e31824b3762. Transplantation. 2012. PMID: 22361472
-
Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?Clin Biochem. 2016 Mar;49(4-5):394-403. doi: 10.1016/j.clinbiochem.2015.05.024. Epub 2015 Jun 26. Clin Biochem. 2016. PMID: 26118475 Review.
Cited by
-
C4d deposits on the surface of RBCs in trauma patients and interferes with their function.Crit Care Med. 2014 May;42(5):e364-72. doi: 10.1097/CCM.0000000000000231. Crit Care Med. 2014. PMID: 24448198 Free PMC article.
-
Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance.Eur J Immunol. 2010 Jun;40(6):1758-67. doi: 10.1002/eji.200940158. Eur J Immunol. 2010. PMID: 20213737 Free PMC article.
-
HLA class I antibody-mediated endothelial and smooth muscle cell activation.Curr Opin Organ Transplant. 2012 Aug;17(4):446-51. doi: 10.1097/MOT.0b013e328355f1c2. Curr Opin Organ Transplant. 2012. PMID: 22710387 Free PMC article. Review.
-
Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.J Heart Lung Transplant. 2012 Nov;31(11):1214-22. doi: 10.1016/j.healun.2012.08.011. Epub 2012 Sep 11. J Heart Lung Transplant. 2012. PMID: 22980951 Free PMC article.
-
Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.Am J Transplant. 2005 Nov;5(11):2778-85. doi: 10.1111/j.1600-6143.2005.01074.x. Am J Transplant. 2005. PMID: 16212640 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources